MCID: HDG009
MIFTS: 15

Hodgkin Lymphoma, Childhood

Categories: Rare diseases, Immune diseases

Aliases & Classifications for Hodgkin Lymphoma, Childhood

MalaCards integrated aliases for Hodgkin Lymphoma, Childhood:

Name: Hodgkin Lymphoma, Childhood 50
Childhood Hodgkin's Lymphoma 50 69

Classifications:



Summaries for Hodgkin Lymphoma, Childhood

MalaCards based summary : Hodgkin Lymphoma, Childhood, also known as childhood hodgkin's lymphoma, is related to non-hodgkin lymphoma, childhood. The drugs Cyclophosphamide and Lenograstim have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and kidney.

Related Diseases for Hodgkin Lymphoma, Childhood

Diseases related to Hodgkin Lymphoma, Childhood via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 non-hodgkin lymphoma, childhood 12.0

Symptoms & Phenotypes for Hodgkin Lymphoma, Childhood

Drugs & Therapeutics for Hodgkin Lymphoma, Childhood

Drugs for Hodgkin Lymphoma, Childhood (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 264)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
2
Lenograstim Approved Phase 4,Phase 3,Phase 2,Phase 1 135968-09-1
3 Thiotepa Approved Phase 4,Phase 2 52-24-4 5453
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
5
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
6
Vinblastine Approved Phase 4,Phase 2,Phase 1 865-21-4 13342 241903
7
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
8 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
9 Antilymphocyte Serum Phase 4,Phase 2,Phase 1
10 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
11 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
12 Antiemetics Phase 4,Phase 3,Phase 2,Phase 1
13 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
14 Antimitotic Agents Phase 4,Phase 3,Phase 2,Phase 1
15 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1
16 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
17 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1
18 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1
19 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1
20 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
21 Hormones Phase 4,Phase 3,Phase 2,Phase 1
22 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
23 Methylprednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1
24 Methylprednisolone Hemisuccinate Phase 4,Phase 3,Phase 2,Phase 1
25 Neuroprotective Agents Phase 4,Phase 2,Phase 1
26 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1
27 Prednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1
28 Prednisolone hemisuccinate Phase 4,Phase 3,Phase 2,Phase 1
29 Prednisolone phosphate Phase 4,Phase 3,Phase 2,Phase 1
30 Protective Agents Phase 4,Phase 3,Phase 2,Phase 1
31
Bleomycin Approved Phase 3,Phase 2 11056-06-7 5360373
32
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
33
Etoposide Approved Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
34
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
35
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
36
Cytarabine Approved, Investigational Phase 2, Phase 3, Phase 1 147-94-4 6253
37
Melphalan Approved Phase 2, Phase 3,Phase 1 148-82-3 4053 460612
38
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3, Phase 1 22916-47-8 4189
39
Cisplatin Approved Phase 3,Phase 2 15663-27-1 84093 441203 2767
40
Dacarbazine Approved, Investigational Phase 3,Phase 2,Phase 1 4342-03-4 5351166
41
Procarbazine Approved Phase 3,Phase 2 671-16-9 4915
42
Busulfan Approved, Investigational Phase 3,Phase 2,Phase 1,Early Phase 1 55-98-1 2478
43
Mechlorethamine Approved Phase 3,Phase 2,Phase 1 51-75-2 4033
44
Vinorelbine Approved, Investigational Phase 3,Phase 1,Phase 2 71486-22-1 60780 44424639
45
Aldesleukin Approved Phase 2, Phase 3, Phase 1 85898-30-2, 110942-02-4
46
Carmustine Approved Phase 2, Phase 3,Phase 1 154-93-8 2578
47
Erythromycin Approved, Vet_approved Phase 3 114-07-8 12560
48
Pentamidine Approved Phase 3 100-33-4 4735
49
Cortisone acetate Approved Phase 3 1950-04-4, 50-04-4 5745
50
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743

Interventional clinical trials:

(show top 50) (show all 219)

id Name Status NCT ID Phase Drugs
1 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
2 Surgery Alone, Surgery With Cyclophosphamide, Vinblastine, and Prednisolone (CVP), or CVP Alone in Treating Young Patients With Stage IA or Stage IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma Recruiting NCT01088750 Phase 4 cyclophosphamide;prednisolone;vinblastine sulfate
3 Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma Completed NCT01026220 Phase 3 doxorubicin hydrochloride;liposomal vincristine sulfate;vinorelbine tartrate;cyclophosphamide;etoposide phosphate;prednisone;ifosfamide
4 Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma Completed NCT00070187 Phase 2, Phase 3 carmustine;cyclosporine;cytarabine;etoposide;melphalan
5 Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease Completed NCT00002827 Phase 3 dexrazoxane hydrochloride;doxorubicin hydrochloride;etoposide;vincristine sulfate
6 Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease Completed NCT00005578 Phase 3 cyclophosphamide;dexrazoxane hydrochloride;doxorubicin hydrochloride;etoposide;prednisone;vincristine sulfate
7 Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease Completed NCT00025259 Phase 3 Cisplatin;Cyclophosphamide;Cytarabine;Dexamethasone;Doxorubicin Hydrochloride;Etoposide;Prednisone;Vincristine Sulfate Liposome
8 Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma Completed NCT00433459 Phase 3 cyclophosphamide;dacarbazine;prednisolone;prednisone;procarbazine hydrochloride;vincristine sulfate
9 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3 piperacillin sodium;piperacillin-tazobactam;tazobactam sodium;vancomycin
10 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
11 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
12 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
13 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
14 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Completed NCT01305200 Phase 3 supersaturated calcium phosphate rinse
15 Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease Completed NCT00003414 Phase 3 busulfan;cyclophosphamide;cyclosporine
16 Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer Completed NCT00002742 Phase 3 amphotericin B deoxycholate;nystatin
17 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
18 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Completed NCT00265837 Phase 3
19 A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families Completed NCT00782145 Phase 3
20 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
21 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
22 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3 acyclovir;acyclovir sodium;valacyclovir
23 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
24 Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma Recruiting NCT02166463 Phase 3 Brentuximab Vedotin;Cyclophosphamide;Doxorubicin Hydrochloride;Etoposide;Prednisone;Vincristine Sulfate
25 Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma Active, not recruiting NCT00302003 Phase 3 doxorubicin hydrochloride;vincristine sulfate;prednisone;cyclophosphamide;ifosfamide;vinorelbine tartrate;dexamethasone;etoposide phosphate;cisplatin;cytarabine
26 Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer Active, not recruiting NCT01987596 Phase 3
27 Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma Unknown status NCT00025064 Phase 2 chlorambucil;cisplatin;dacarbazine;doxorubicin hydrochloride;etoposide;ifosfamide;melphalan;prednisolone;procarbazine hydrochloride;vinblastine sulfate;vincristine sulfate
28 Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders Unknown status NCT00008307 Phase 2 cyclosporine;fludarabine phosphate;melphalan;methylprednisolone;mycophenolate mofetil
29 Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases Unknown status NCT00084695 Phase 2 busulfan;cyclophosphamide;fludarabine phosphate;melphalan;methylprednisolone
30 Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma Unknown status NCT00621036 Phase 2 methotrexate;thiotepa
31 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
32 Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia Unknown status NCT00008164 Phase 2
33 Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation Unknown status NCT00036712 Phase 2
34 A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942) Completed NCT00592111 Phase 2 COPP/ABV;COPP/ABV;intensive chemo with concurrent growth factor
35 Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma Completed NCT00416832 Phase 2 cyclophosphamide;dacarbazine;doxorubicin hydrochloride;etoposide;prednisone;procarbazine hydrochloride;vincristine sulfate
36 Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma Completed NCT00006029 Phase 1, Phase 2 gemcitabine hydrochloride;pegylated liposomal doxorubicin hydrochloride;vinorelbine tartrate
37 Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma Completed NCT00003631 Phase 2 carboplatin;carmustine;cyclophosphamide;cytarabine;etoposide;ifosfamide;melphalan
38 Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease Completed NCT00004169 Phase 2 carboplatin;cyclophosphamide;etoposide
39 Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma Completed NCT00398554 Phase 2 cyclophosphamide;doxorubicin hydrochloride;etoposide;prednisone;vinblastine sulfate;vincristine sulfate
40 Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy Completed NCT00381940 Phase 2 ifosfamide;bortezomib;vinorelbine tartrate
41 Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer Completed NCT00049504 Phase 2 cyclophosphamide;fludarabine phosphate;tacrolimus;mycophenolate mofetil
42 Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma Completed NCT00006760 Phase 2 ifosfamide;vinorelbine tartrate
43 Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma Completed NCT00070304 Phase 2 gemcitabine hydrochloride;vinorelbine tartrate
44 Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00489203 Phase 2 beclomethasone dipropionate;placebo;tacrolimus;methotrexate
45 Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease Completed NCT00004010 Phase 2 ABVD regimen;cyclophosphamide;dacarbazine;doxorubicin hydrochloride;etoposide;prednisone;procarbazine hydrochloride;vinblastine sulfate;vincristine sulfate
46 Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00027937 Phase 2 busulfan;cyclophosphamide;melphalan;paclitaxel;thiotepa
47 Study of @neWorld: A Virtual Community for Children With Cancer Completed NCT00070421 Phase 1, Phase 2
48 Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma Completed NCT00238433 Phase 2 busulfan;melphalan;thiotepa
49 Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment Completed NCT00066248 Phase 2 cyproheptadine hydrochloride;megestrol acetate
50 Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Completed NCT00002502 Phase 2 busulfan;cyclophosphamide;cytarabine

Search NIH Clinical Center for Hodgkin Lymphoma, Childhood

Genetic Tests for Hodgkin Lymphoma, Childhood

Anatomical Context for Hodgkin Lymphoma, Childhood

MalaCards organs/tissues related to Hodgkin Lymphoma, Childhood:

39
Bone, Bone Marrow, Kidney, Brain, Breast, T Cells, B Cells

Publications for Hodgkin Lymphoma, Childhood

Variations for Hodgkin Lymphoma, Childhood

Expression for Hodgkin Lymphoma, Childhood

Search GEO for disease gene expression data for Hodgkin Lymphoma, Childhood.

Pathways for Hodgkin Lymphoma, Childhood

GO Terms for Hodgkin Lymphoma, Childhood

Sources for Hodgkin Lymphoma, Childhood

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....